0001486189-24-000022.txt : 20240408
0001486189-24-000022.hdr.sgml : 20240408
20240408150742
ACCESSION NUMBER: 0001486189-24-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240331
FILED AS OF DATE: 20240408
DATE AS OF CHANGE: 20240408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Intrater James
CENTRAL INDEX KEY: 0001950394
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41097
FILM NUMBER: 24829353
MAIL ADDRESS:
STREET 1: C/O CARDIO DIAGNOSTICS HOLDINGS INC.
STREET 2: 400 N. ABERDEEN ST., SUITE 900
CITY: CHICAGO
STATE: IL
ZIP: 60642
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardio Diagnostics Holdings, Inc.
CENTRAL INDEX KEY: 0001870144
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 870925574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 311 W. SUPERIOR STREET
STREET 2: SUITE 444
CITY: CHICAGO
STATE: IL
ZIP: 60645
BUSINESS PHONE: 855-226-9991
MAIL ADDRESS:
STREET 1: 311 W. SUPERIOR STREET
STREET 2: SUITE 444
CITY: CHICAGO
STATE: IL
ZIP: 60645
FORMER COMPANY:
FORMER CONFORMED NAME: Mana Capital Acquisition Corp.
DATE OF NAME CHANGE: 20210629
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-03-31
0
0001870144
Cardio Diagnostics Holdings, Inc.
CDIO
0001950394
Intrater James
C/O CARDIO DIAGNOSTICS HOLDINGS INC.
311 W. SUPERIOR ST. SUITE 444
CHICAGO
IL
60654
1
0
0
0
0
Common Stock
2024-03-31
4
M
0
8803
1.42
A
71596
D
Restricted Stock Units
0
2024-03-31
4
M
0
12500
0
A
2024-03-31
2024-12-31
Common Stock
12500
37500
D
Represents the settlement of restricted stock units (RSUs) that vested on March 31, 2024 through the issuance of shares of Common Stock.
Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.
On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date.
The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.
/s/ Elisa Luqman as attorney-in-fact for James Intrater
2024-04-08